1
|
Van KL, Bruce H, Dennington P, Hull S, Yin Kwok AC, Partridge J, Ackerman L, Khoo TL. Management of a rare red cell antibody in pregnancy. Pathology 2023. [DOI: 10.1016/j.pathol.2022.12.323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
2
|
Lucas R, Dennington P, Wood E, Murray KJ, Cheng A, Burgner D, Singh-Grewal D. Epidemiology of Kawasaki disease in Australia using two nationally complete datasets. J Paediatr Child Health 2022; 58:674-682. [PMID: 34716731 DOI: 10.1111/jpc.15816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/19/2021] [Revised: 08/17/2021] [Accepted: 10/10/2021] [Indexed: 11/28/2022]
Abstract
AIM The incidence of Kawasaki disease (KD) is reported to be increasing in some populations. We sought to describe long-term trends in the incidence and epidemiology of KD in Australia over 25 years. METHODS Two nationally complete administrative datasets relevant to KD in Australia were analysed and compared. The Australian Red Cross Lifeblood Supply Tracking Analysis Reporting System (STARS) recorded all doses of immunoglobulin (IVIG) approved in Australia between January 2007 and June 2016. The Australian Institute of Health and Welfare National Hospital Morbidity Database (NHMD) records all episodes of care in hospitals across Australia. Data relevant to KD were extracted an analysed, with comparisons made for the period of data overlap. RESULTS During the period of data overlap (2007-2015) the IVIG treatment rate in the 0- to 4-year age group (calculated from STARS) was 14.31 per 100 000 person-years (95% confidence interval 13.67-14.97). The hospitalisation rate in the same age group (calculated from the NHMD) was 14.99 per 100 000 person-years (95% confidence interval 14.33-15.66). Hospitalisation rates rose at an average rate of 3.54% annually over the 25 years to 2017 in the 0- to 4-year age group, almost exclusively in the 1- to 4-year age group. CONCLUSIONS There is evidence of increasing KD diagnosis in Australia. Similar trends have also been reported in Asia but not in North America or Europe. Increasing diagnosis may reflect a true increase in disease incidence, increasing recognition or overdiagnosis. Further research is needed to determine the cause for these trends.
Collapse
Affiliation(s)
- Ryan Lucas
- Faculty of Medicine and Health, Discipline of Child and Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia.,Department of General Medicine, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia
| | - Peta Dennington
- Transfusion Medicine Services Team, Australian Red Cross Lifeblood New South Wales and Australian Capital Territory, Sydney, New South Wales, Australia
| | - Erica Wood
- Transfusion Research Unit, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia.,Department of Clinical Haematology, Monash Health, Melbourne, Victoria, Australia
| | - Kevin J Murray
- Department of Rheumatology, Perth Children's Hospital, Perth, Western Australia, Australia
| | - Allen Cheng
- Department of Infectious Diseases, Alfred Health, Infection Prevention and Healthcare Epidemiology Unit, Melbourne, Victoria, Australia.,Infectious Disease Epidemiology Unit, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia
| | - David Burgner
- Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.,Melbourne Medical School, Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia
| | - Davinder Singh-Grewal
- Faculty of Medicine and Health, Discipline of Child and Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia.,Department of General Medicine, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia.,School of Women's and Children's Health, University of New South Wales Faculty of Medicine, Sydney, New South Wales, Australia
| |
Collapse
|
3
|
Li EW, Di Ciaccio P, Fan K, Taper J, Dennington P. Atypical presentation of IgA-related immediate reaction with back pain and relative hypotension – anaphylaxis or not? Pathology 2021. [DOI: 10.1016/j.pathol.2021.06.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Lucas R, Dennington P, Wood E, Dionne A, de Ferranti SD, Newburger JW, Dahdah N, Cheng A, Burgner D, Singh-Grewal D. Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatricians. J Paediatr Child Health 2021; 57:646-652. [PMID: 33296115 DOI: 10.1111/jpc.15290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Revised: 11/12/2020] [Accepted: 11/14/2020] [Indexed: 11/29/2022]
Abstract
AIM This study aimed to describe the current management practices for Kawasaki disease (KD) in Australia and New Zealand. METHODS We performed a secondary analysis on the Australian and New Zealand responses to a large international survey of clinicians' perspectives on KD diagnosis and management. RESULTS There was general consensus among Australian and New Zealand clinicians regarding the indications for intravenous immunoglobulin and aspirin in the management of acute KD. There was less consensus on the dose of these agents, the definition and management of treatment-resistant KD and the approach to long-term thromboprophylaxis. CONCLUSION Most clinicians use intravenous immunoglobulin for primary treatment of KD. There is variation regarding other aspects of KD diagnosis and important management issues. Future studies should confirm whether this reported variation occurs in real-world practice and assess potential impacts on patient outcome.
Collapse
Affiliation(s)
- Ryan Lucas
- Department of General Medicine, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia.,Children's Hospital Westmead Clinical School, Discipline of Child and Adolescent Health, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia
| | - Peta Dennington
- Australian Red Cross Lifeblood, Sydney, New South Wales, Australia
| | - Erica Wood
- Transfusion Research Unit, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia
| | - Audrey Dionne
- Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, United States.,Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States
| | - Sarah D de Ferranti
- Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, United States.,Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States
| | - Jane W Newburger
- Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, United States.,Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States
| | - Nagib Dahdah
- Department of Pediatric Cardiology, University of Montreal, Montreal, Quebec, Canada
| | - Allen Cheng
- Infectious Disease Epidemiology Unit, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia
| | - David Burgner
- Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia
| | - Davinder Singh-Grewal
- Department of General Medicine, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia.,Children's Hospital Westmead Clinical School, Discipline of Child and Adolescent Health, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.,School of Women's and Children's Health, University of New South Wales Faculty of Medicine, Sydney, New South Wales, Australia
| |
Collapse
|
5
|
Li EW, Di Ciaccio P, Springell D, Fan K, Taper J, Dennington P. Atypical presentation of iga-related immediate reaction with back pain and relative hypotension – Anaphylaxis or not? Pathology 2020. [DOI: 10.1016/j.pathol.2020.01.388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
6
|
Morton S, Stanworth S, Lozano M, Harrison S, Hong F, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner J, Yokoyama A, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D. Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use. Vox Sang 2017; 112:e48-e68. [DOI: 10.1111/vox.12523] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S. Morton
- NHS Blood and Transplant; University Hospitals Birmingham NHS Foundation Trust; Birmingham UK
| | - S. Stanworth
- NHS Blood and Transplant; Oxford University Hospital NHS Foundation Trust; Oxford UK
| | | | - S.J. Harrison
- Peter MacCallum Cancer Centre; Melbourne Vic. Australia
- Victoria Comprehensive Cancer Centre, Grattan Street; Melbourne Vic. 3000 Australia
- Sir Peter MacCallum Department of Oncology; Melbourne University; Melbourne Vic. 3000 Australia
| | - F.S. Hong
- Clinical Services and Research; Australian Red Cross Blood Service; 100 Batman St West Melbourne Vic. 3003 Australia
| | - P. Dennington
- Clinical Services and Research; Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - Z. McQuilten
- Department of Epidemiology and Preventive Medicine; Monash University; Level 6, 99 Commercial Road Melbourne Vic. 3001 Australia
| | - N. Worel
- Department of Blood Group Serology and Transfusion Medicine; Medical University Vienna; Waehringer Guertel 18-20 A-1090 Vienna Austria
| | - V. Compernolle
- Belgian Red Cross-Flanders; Blood Services; Ottergemsesteenweg 413 B-9000 Ghent Belgium
| | - J.M. Kutner
- Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 - Banco de Sangue 05651-901 Sao Paulo SP Brazil
| | - A.P.H. Yokoyama
- Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 - Banco de Sangue 05651-901 Sao Paulo SP Brazil
| | - S. Nahirniak
- Department of Laboratory Medicine and Pathology; University of Alberta; 4B1.23 WMC 8440-112 St. Edmonton AB T6G 2B7 Canada
| | - M. Germain
- Medical Affairs; Héma-Québec; 1070 Sciences-de-la-Vie Ave Québec QC G1V 5C3 Canada
| | - H. Hume
- Département de Pédiatrie; Université de Montréal Service d'Hématologie/Oncologie; CHU Sainte-Justine 3175 Côte-Sainte-Catherine Montréal QC H3T 1C5 Canada
| | - N. Robitaille
- Département de Pédiatrie; Université de Montréal Service d'Hématologie/Oncologie; CHU Sainte-Justine 3175 Côte-Sainte-Catherine Montréal QC H3T 1C5 Canada
| | - A. Wilson
- Department of Hematology; McGill University Health Centre; 1001 Boul. Décarie Montréal QC Canada
| | - A. Tinmouth
- Benign Hematology and Transfusion Medicine; Ottawa Hospital and Ottawa Hospital Research Institute; 501 Smyth Rd Box 201a Ottawa ON K1H 8L6 Canada
| | - E. Massey
- Benign Hematology and Transfusion Medicine; Ottawa Hospital and Ottawa Hospital Research Institute; 501 Smyth Rd Box 201a Ottawa ON K1H 8L6 Canada
| | - C. Boulat
- Etablissement Français du Sang; 20 Avenue du Stade de France 93218 La Plaine St Denis Cedex France
| | - G. Woimant
- Etablissement Français du Sang; 20 Avenue du Stade de France 93218 La Plaine St Denis Cedex France
| | - P. Tiberghien
- Etablissement Français du Sang; 20 Avenue du Stade de France 93218 La Plaine St Denis Cedex France
| | - T. J. Schulze
- Institute of Transfusion Medicine and Immunology; Medical Faculty Mannheim; Heidelberg University; German Red Cross Blood Service Baden-Württemberg - Hessen Friedrich-Ebert-Str. 107 68167 Mannheim Germany
| | - J. Bux
- University of Bochum; Linnenkamp 19 Hagen 58093 Germany
| | - L. Pierelli
- Transfusion Medicine and Stem Cells; San Camillo Forlanini Hospital; Circonvallazione Gianicolense 87 00152 Rome Italy
| | - C. Ballester
- Department Hematology and Hemotherapy; Son Espases University Hospital; Carretera de Valldemossa 79 07010 Palma de Mallorca Spain
| | - T. Netelenbos
- Internist-hematologist and transfusion specialist; Department of Immunohematology and Blood Transfusion, E3Q; Leids University Medical Center; Postbus 9600 2300RC Leiden The Netherlands
| | - K. A. West
- Department of Transfusion Medicine; National Institutes of Health Clinical Center; 10 Center Drive Room 1N226 Bethesda MD 20892 USA
| | - C. Conry-Cantilena
- Blood Services Section; NIH/CC/DTM; Building 10 Room 1C711 Bethesda MD 20892 USA
| | - A. Eder
- Blood Services Section; NIH/CC/DTM; Building 10 Room 1C711 Bethesda MD 20892 USA
| | - N. R. Haley
- Bloodworks Northwest; Medical Services; 921 Terry Avenue Seattle WA 98104 USA
| | - M. Yazer
- University of Pittsburgh; Pittsburgh; PA USA
- University of Southern Denmark; Odense Denmark
| | - D. Triulzi
- Division of Transfusion Medicine; Department of Pathology; University of Pittsburgh Pittsburgh PA USA
| |
Collapse
|
7
|
Morton S, Stanworth S, Lozano M, Harrison S, Hong F, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner J, Yokoyama A, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze T, Bux J, Pierelli L, Ballester C, Netelenbos T, West K, Conry-Cantilena C, Eder A, Haley N, Yazer M, Triulzi D. Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary. Vox Sang 2017; 112:680-683. [DOI: 10.1111/vox.12522] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S. Morton
- NHS Blood and Transplant; University Hospitals Birmingham NHS Foundation Trust; Vicent Drive Edgbaston Birmingham B15 2SG UK
| | - S. Stanworth
- NHSBT/Oxford University Hospital NHS Foundation Trust; Radcliffe Department of Medicine; John Radcliffe Hospital; University of Oxford; Headington, Oxford OX3 9BQ UK
| | - M. Lozano
- Department of Hemotherapy and Hemostasis; University Clinic Hospital; University of Barcelona; Villarroel 170 08036 Barcelona Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, Meng Y, Qian K, Rehacek V, Turek P, Krusius T, Juvonen E, Tiberghien P, Legrand D, Semana G, Muller JY, Bux J, Reil A, Lin CK, Daly H, McSweeney E, Porretti L, Greppi N, Rebulla P, Okazaki H, Sánchez-Guerrero SA, Baptista-González HA, Martínez-Murillo C, Guerra-Márquez A, Rodriguez-Moyado H, Middelburg RA, Wiersum-Osselton JC, Brand A, van Tilburg C, Dinesh D, Dagger J, Dunn P, Brojer E, Letowska M, Maslanka K, Lachert E, Uhrynowska M, Zhiburt E, Palfi M, Berlin G, Frey BM, Puig Rovira L, Muñiz-Diaz E, Castro E, Chapman C, Green A, Massey E, Win N, Williamson L, Silliman CC, Chaffin DJ, Ambruso DR, Blumberg N, Tomasulo P, Land KJ, Norris PJ, Illoh OC, Davey RJ, Benjamin RJ, Eder AF, McLaughlin L, Kleinman S, Panzer S. Measures to prevent transfusion-related acute lung injury (TRALI). Vox Sang 2012; 103:231-59. [DOI: 10.1111/j.1423-0410.2012.01596.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Lee A, Permezel M, Dennington P, Duke T, Doyle L, Robinson H. Neonatal alloimmune thrombocytopenia. A case report and a review of the literature. Aust N Z J Obstet Gynaecol 1993; 33:420-3. [PMID: 8179559 DOI: 10.1111/j.1479-828x.1993.tb02127.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
A 32-year-old woman in her third pregnancy underwent fetal blood sampling because of a previous child with neonatal thrombocytopenia. At 33 weeks' gestation, fetal thrombocytopenia was diagnosed. Treatment was instituted antenatally with serial fetal platelet transfusions and corticosteroid therapy. Delivery was by Caesarean section at 37 weeks' gestation. Neonatal treatment included further platelet transfusion and immunoglobulin infusion. Recovery of the neonate was complete on discharge from hospital 10 days after birth. The aetiology, diagnosis, clinical presentations and therapeutic options in cases of alloimmune thrombocytopenia are discussed.
Collapse
Affiliation(s)
- A Lee
- Royal Women's Hospital, University of Melbourne, Carlton
| | | | | | | | | | | |
Collapse
|
10
|
Dennington P, Holdsworth R, Tippett C, Coghlan P. Antenatal treatment of neonatal alloimmune thromeocytopenia(NAIT) with intravenous cammaglobulin. Pathology 1993. [DOI: 10.1016/s0031-3025(16)35748-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|